Using Cannabidiol to Help with Opioid Addiction and Chronic Pain
Cannabidiol Pharmacotherapy for Comorbid Opioid Addiction and Chronic Pain
This study is looking at how Cannabidiol (CBD) might help people who are dealing with both chronic pain and opioid use disorder by seeing if it can reduce their pain and cravings for opioids, offering a new treatment option for those in need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11077231 on NIH RePORTER |
What this research studies
This research investigates how Cannabidiol (CBD) can help individuals who suffer from both opioid use disorder and chronic pain. It aims to assess the effectiveness of CBD in reducing pain sensitivity and cravings for opioids through a combination of behavioral assessments and pain testing methods. By focusing on the safety and therapeutic potential of CBD, the study seeks to provide a new treatment option for those struggling with these comorbid conditions. Participants will undergo various tests to measure their pain responses and cravings, contributing to a better understanding of CBD's role in pain management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who also experience chronic pain.
Not a fit: Patients who do not have opioid use disorder or chronic pain may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new, effective treatment option for patients dealing with both opioid addiction and chronic pain.
How similar studies have performed: Previous research has shown promising results for cannabinoids in pain management and addiction treatment, indicating potential success for this approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: De Aquino, Joao Paulo — Yale University
- Study coordinator: De Aquino, Joao Paulo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.